Ashton Thomas Private Wealth LLC Sells 580 Shares of Intuitive Surgical, Inc. $ISRG

Ashton Thomas Private Wealth LLC cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.1% during the second quarter, Holdings Channel reports. The fund owned 2,046 shares of the medical equipment provider’s stock after selling 580 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Intuitive Surgical were worth $1,112,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Solstein Capital LLC grew its position in Intuitive Surgical by 104.1% during the 2nd quarter. Solstein Capital LLC now owns 151 shares of the medical equipment provider’s stock worth $82,000 after acquiring an additional 77 shares during the last quarter. Chilton Capital Management LLC grew its position in Intuitive Surgical by 554.0% during the 2nd quarter. Chilton Capital Management LLC now owns 327 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 277 shares during the last quarter. Resonant Capital Advisors LLC grew its position in Intuitive Surgical by 16.9% during the 2nd quarter. Resonant Capital Advisors LLC now owns 1,816 shares of the medical equipment provider’s stock worth $987,000 after acquiring an additional 262 shares during the last quarter. Wealthfront Advisers LLC grew its position in Intuitive Surgical by 3.3% during the 2nd quarter. Wealthfront Advisers LLC now owns 46,167 shares of the medical equipment provider’s stock worth $25,088,000 after acquiring an additional 1,481 shares during the last quarter. Finally, New Hampshire Trust grew its position in Intuitive Surgical by 13.2% during the 2nd quarter. New Hampshire Trust now owns 796 shares of the medical equipment provider’s stock worth $433,000 after acquiring an additional 93 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Down 1.4%

ISRG stock opened at $537.59 on Thursday. The business’s fifty day moving average is $461.96 and its 200-day moving average is $498.01. The company has a market cap of $192.72 billion, a P/E ratio of 71.11, a price-to-earnings-growth ratio of 5.01 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.84 EPS. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Wells Fargo & Company increased their price target on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. HSBC increased their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. BTIG Research increased their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Finally, Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 7,562 shares of the stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $193,595.79. This represents a 95.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 2,193 shares of the stock in a transaction on Friday, October 24th. The shares were sold at an average price of $548.01, for a total value of $1,201,785.93. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 96,011 shares of company stock worth $50,309,042 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.